Okay, well now I can think of one time good news caused this stock to move. Obviously, this PR is different. For one thing, it's nice to see an actual contract for a change, instead of another imminently doomed letter of intent, and it's nice to see some actual dollars changing hands, too. But that is not what I mean. I suspect those of you who have been around for a while, like me, take particular satisfaction in today's actions. The old guard like us bought this stock years ago because of the Ii-Key technology, among other things. I, for one, have never lost faith in Antigen Express or its ability to create highly-immunogenic peptides. The Ii-Key-COVID-19 peptide vaccine is for real. Antigen Express is for real, and real scientists run it. This will be a very effective vaccine, and it should be available early, maybe even the first construct to start human trials.**
**Note: this statement applies to every future outbreak and pandemic.
I'm a molecular biology nerd. I don't give a crap about surgical equipment or pharmacies. The only thing I know about an MSO is that they screw up my billing all the time. I do not invest in companies that do those sorts of things. I invest in companies that have technology to make really good vaccines really quickly. I am looking forward to seeing what Antigen Express can do as a stand alone company. I hope this positive blip for GNBT does not cause a delay in the delivery of our sweet baby. Joe, if you love it, set it free...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.